Environment And Sanitation Tenders

Completion of Non-exclusive Drug Discounts According to Section 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Fondaparinux (atc Code According to Who: B01ax05)

Completion of Non-exclusive Drug Discounts According to Section 130a (8) Sgb V by Means of a So-called Open-house Model to the Active Ingredient Epoetin Zeta (recombinant Human Erythropoetin)

Drug Discount Contracts with Option to Join - 0018-Rvbeitr.61-2023

Open House Biologics Rebate Agreements 2023-05 - Dornase Alfa

Drug Discount Contracts with Option to Join - 0015-Rvbeitr.60-2023

Medicinal Products with the Active Ingredient Octreotide (Atc: H01cb02 - no Sustained-Release Dosage Forms)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Interferon Beta 1B, Atc Code: L03ab08 for the Period from May 1St, 2023 to April 30Th, 2025

Open House Drug Rebate Contracts Somatropin, Atc H01ac01

Medicinal Products with the Active Ingredient Octreotide (Atc: H01cb02 - Prolonged-Release Dosage Forms)

Completion of a Non-Excl. Discount Agreement According to § 130A Paragraph 8 Sgb V for Tezepelumab, Atc Code: R03dx11 for the Period from May 1St, 2023 to April 30Th, 2025